NORTHWEST BIOTHERAPEUTICS INC Common Stock

YTD

ALL

Why Robinhood?

You can watch NWBO and buy or sell other stocks, ETFs, and their options commission-free!

About NWBO

Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient’s own immune system to attack their cancer.

CEO

Linda F. Powers

CEOLinda F. Powers

Employees

Employees25

Headquarters

Bethesda, Maryland

HeadquartersBethesda, Maryland

Founded

1996

Founded1996

Employees

Employees25

NWBO Key Statistics

Market cap

374.62M

Market cap374.62M

Price-Earnings ratio

-4.00

Price-Earnings ratio-4.00

Dividend yield

—

Dividend yield—

Average volume

6.65M

Average volume6.65M

High today

$0.255

High today$0.255

Low today

$0.246

Low today$0.246

Open price

$0.255

Open price$0.255

Volume

7.61M

Volume7.61M

52 Week high

$0.4788

52 Week high$0.4788

52 Week low

$0.1685

52 Week low$0.1685

NORTHWEST BIOTHERAPEUTICS INC Common Stock

Why Robinhood?

Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient’s own immune system to attack their cancer. Show more

NWBO Key Statistics

Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient’s own immune system to attack their cancer.